News Sentiment

TVGN sentiment intelligence

Tevogen Bio Holdings Inc. news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed

Weighted score 50 Balanced news tone 55 relevant articles

Exchange NASDAQ United States

Sector Healthcare Market context

Industry Biotechnology Read-through group

Latest close 5.06 Week of 10 Jul 2026

Weighted tone 50/100

Balanced news tone

Market reaction Price moving ahead of tone

Price is moving more forcefully than the current news tone suggests.

Primary event Market update

83/100 classification confidence.

Company focus 46

directly relevant articles

Source quality 0

high-authority source matches

Trend context Trend inactive

-12.3% over one week, -51.7% over four weeks, trend inactive, and below fair value.

Latest direct headline Neutral

Dr. Saadi boosts control at Tevogen Bio Holdings (TVGN) with stock grant

Market Reaction

Price moving ahead of tone

59/100 confidence

Primary event Market update 83/100 classification

One-week reaction -12.3% Price reacting lower

Trend fit Trend inactive -51.7% over four weeks

Fair value -91.1% Below fair value

Value support

Sentiment Mix

Positive, neutral, negative

Weighted by relevance

Positive 3

Neutral 50

Negative 2

Relevance

Why the article matched

Direct first

Direct company coverage 46

Industry context 9

Sector context 0

Sources

Coverage mix

Publishers

Stock Titan 17

TradingView 9

Market source 8

TradingKey 6

GlobeNewswire 5

Investing.com Nigeria 2

simplywall.st 2

BioSpace 1

Event Lens

What the news is about

Classified themes

Market update 34

Earnings 16

Deals and strategy 4

Balance sheet 1

Sentiment Trail

Score over time

50 baseline

Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 31-55 of 55

TradingKey Direct company coverage

Tevogen Bio Holdings Inc (TVGN) Financial Health: Profitability & Balance Sheet Analysis

This article provides an analysis of Tevogen Bio Holdings Inc (TVGN) financial health using TradingKey's stock score system. The analysis highlights that relevant financial data for profitability, operational efficiency, growth potential, and shareholder returns have not been dis

Tone: Neutral 50/100
Event: Market update
Published: 18 Jun 2026 06:09
Source: TradingKey

GlobeNewswire Direct company coverage

Tevogen Announces Formation of a Healthcare Services Initiative

Tone: Neutral 50/100
Event: Market update
Published: 09 Jun 2026 19:30
Source: GlobeNewswire

Stock Titan Direct company coverage

Tevogen weighs $100M in potential MSO, CRO revenue with new unit

Tone: Neutral 50/100
Event: Earnings
Published: 09 Jun 2026 07:00
Source: Stock Titan

GlobeNewswire Direct company coverage

Tevogen Advances Strategic Acquisition Initiatives with Potential to Support Approximately $100 Million in Combined Annual Revenue

Tone: Neutral 50/100
Event: Deals and strategy
Published: 28 May 2026 16:30
Source: GlobeNewswire

Stock Titan Direct company coverage

Tevogen outlines biotech, AI and healthcare services vision

Tone: Neutral 50/100
Event: Market update
Published: 28 May 2026 07:00
Source: Stock Titan

GlobeNewswire Direct company coverage

Tevogen Signs Letter of Intent to Evaluate Potential Acquisition of a Management Services Organization

Tone: Neutral 50/100
Event: Deals and strategy
Published: 21 May 2026 16:15
Source: GlobeNewswire

simplywall.st Industry context

There May Be Reason For Hope In Puma Biotechnology's (NASDAQ:PBYI) Disappointing Earnings

Tone: Negative 34/100
Event: Earnings
Published: 15 May 2026 07:00
Source: simplywall.st

Market source Industry context

Puma Biotechnology's (NASDAQ:PBYI) Conservative Accounting Might Explain Soft Earnings

Tone: Neutral 50/100
Event: Earnings
Published: 14 May 2026 07:00
Source: Market source

GlobeNewswire Direct company coverage

Tevogen Announces $3 Million Private Investment at $8 Per Share, a 14% Premium from Latest Market Close

Tone: Neutral 50/100
Event: Market update
Published: 12 May 2026 15:45
Source: GlobeNewswire

Stock Titan Direct company coverage

Existing backer pays 14% premium in Tevogen’s new $3M cash raise

Tone: Positive 66/100
Event: Balance sheet
Published: 12 May 2026 07:00
Source: Stock Titan

simplywall.st Industry context

Puma Biotechnology, Inc. (NASDAQ:PBYI) Analysts Are Pretty Bullish On The Stock After Recent Results

Tone: Positive 66/100
Event: Earnings
Published: 11 May 2026 07:00
Source: simplywall.st

Market source Industry context

Earnings Update: Here's Why Analysts Just Lifted Their Puma Biotechnology, Inc. (NASDAQ:PBYI) Price Target To US$5.00

Tone: Neutral 50/100
Event: Earnings
Published: 11 May 2026 07:00
Source: Market source

Insider Monkey Direct company coverage

Tevogen (TVGN) Soars 11% as Firm Gears Up for AI Training Commercialization

Tone: Neutral 50/100
Event: Market update
Published: 05 May 2026 01:24
Source: Insider Monkey

Stock Titan Direct company coverage

Tevogen Bio (NASDAQ: TVGN) adds governance, pay and related-party details

Tone: Neutral 50/100
Event: Market update
Published: 30 Apr 2026 07:00
Source: Stock Titan

GlobeNewswire Direct company coverage

Tevogen.AI Nears Completion of PredicTcell™ Training; Initiates Commercial Readiness and Debuts Internal Application Portal

Tone: Neutral 50/100
Event: Market update
Published: 27 Apr 2026 15:50
Source: GlobeNewswire

Market source Industry context

Q4 Earnings Highlights: Regeneron (NASDAQ:REGN) Vs The Rest Of The Biotechnology Stocks

Tone: Neutral 50/100
Event: Earnings
Published: 25 Apr 2026 07:00
Source: Market source

Stock Titan Direct company coverage

Tevogen Bio (NASDAQ: TVGN) warned on Nasdaq $50M, $15M value tests

Tone: Neutral 50/100
Event: Market update
Published: 22 Apr 2026 07:00
Source: Stock Titan

Market source Industry context

Biotechnology Stocks Q3 Results: Benchmarking Natera (NASDAQ:NTRA)

Tone: Neutral 50/100
Event: Earnings
Published: 21 Apr 2026 07:00
Source: Market source

TradingView Industry context

A Look Back at Biotechnology Stocks’ Q4 Earnings: Incyte (NASDAQ:INCY) Vs The Rest Of The Pack

Tone: Neutral 50/100
Event: Earnings
Published: 29 Mar 2026 07:00
Source: TradingView

Trefis Direct company coverage

Tevogen Bio (TVGN) Stock Pre-Market (-4.1%): New Diversified Strategy Met With Skepticism

Tone: Neutral 50/100
Event: Market update
Published: 11 Mar 2026 07:00
Source: Trefis

Stock Titan Direct company coverage

Inside Tevogen's $50M expansion push and the team picked to run it

Tone: Positive 66/100
Event: Market update
Published: 09 Mar 2026 07:00
Source: Stock Titan

Market source Direct company coverage

Tevogen Advances Generics Strategy, Signs Letter of Intent to Evaluate Potential Acquisition of Apozeal Pharmaceutical

Tone: Neutral 50/100
Event: Deals and strategy
Published: 05 Mar 2026 08:00
Source: Market source

Market source Direct company coverage

Tevogen Announces Reverse Stock Split

Tone: Neutral 50/100
Event: Market update
Published: 04 Mar 2026 08:00
Source: Market source

Market source Direct company coverage

Analysts Expect Breakeven For Tevogen Bio Holdings Inc. (NASDAQ:TVGN) Before Long

Tone: Neutral 50/100
Event: Market update
Published: 09 Dec 2025 08:00
Source: Market source

MarketBeat Direct company coverage

Tevogen Bio (TVGN) Stock Price, News & Analysis

Tone: Neutral 50/100
Event: Market update
Published: 18 Feb 2024 13:08
Source: MarketBeat